Introduction In medicine, women’s health refers to the category of conditions and experiences that are unique to women such as pregnancy and menstruation. The term can also be applied to conditions experienced by both men […]
Orally delivered APIs must survive the harsh acidic conditions of the upper gastrointestinal tract to reach their target destination and remain viable. To overcome this challenge Lonza Capsules & Health Ingredients have developed groundbreaking enteric […]
Asthma is a major cause of disability, poor quality of life world-wide and health resource utilization. The World Health Organisation (WHO) estimated that 262 million people suffered from asthma in 2019 and it caused 455 […]
We are faced with the generation of very large volumes of complex NGS data, which presents a huge challenge for its analysis, and with the question how we can derive a simple scientific interpretation and […]
As interest in microbiome is rapidly growing globally, the Greater Copenhagen region – spanning Eastern Denmark and the southernmost part of Sweden – offers international businesses and researchers a unique combination of a rich ecosystem […]
The regulatory environment for live biotherapeutic products is still uncertain globally, of course, but one booming area is the manufacturing of these products as they move through their clinical development process. Adrien Nivoliez, CEO of Biose Industrie reflects on […]
Every microbiome-focused company has its own approach for discovering drug candidates—but rarely is the mechanism of action for a live biotherapeutic product (LBP) known from the outset. Microbiome pharma company ImmunoBiome, however, uses a unique […]
With increasing evidence for microbial involvement in many human diseases, live biotherapeutic products (LBPs)—living microbes administered therapeutically—have emerged as a group of exciting new drug candidates. Although the LBP regulatory environment remains uncertain, companies all […]
Following Biofortis first paper The human microbiome: a global overview of clinical trials activity, this article compares the emergence of the human microbiome field with the rise of human genomics through a review on how […]
While“healthy” microbiome remains to be defined, microbiome disruption is associated with numerous diseases, offering new therapeutic opportunities if causalities are demonstrated. Europe is at the forefront of the understanding of the Microbiome and is well placed […]